Multiple sclerosis and depression: influence of interferon b therapy
The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Abstract
Background and objectives: Depression is frequently part of the clinical picture of multiple sclerosis (MS). Major depression affects one in two patients with MS during the course of their lifetime. O ur objectives were to determine first, whether interferon b-1a (IFNb-1a) treatment increases the risk or level of depression and, secondly, whether depression status and depression evolution are related to the clinical characteristics of the disease. Patients and methods: We investigated 106 consecutive patients with relapsing-remitting MS treated with IFNb-1a (Avonex®). Patients with evidence of severe depression were excluded. The depression status, scored on the Beck Depression Inventory (BDI-II) (stratified as minimum, mild, moderate or severe level), and disability, scored on the Expanded Disability Status Scale (EDSS), were evaluated before and after 12 months of IFNb-1a treatment. Results: At baseline, 85% of patients had a minimum or a mild depression status and after 12 months of treatment most of them (83%) retained their baseline status. Beck scores before and after treatment were not significantly different (P =0.63). There was no correlation between age, gender, duration of illness or EDSS score and Beck score at baseline (P =0.696). Patients with disability progression after one year of IFNb-1a treatment had a significantly higher Beck score at baseline than patients without disability progression (P =0.003). Conclusion: IFNb-1a (Avonex®) does not seem to significantly influence the depression status of MS patients even in those with disability progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kappos, L. (1998) · The Lancet · doi:10.1016/s0140-6736(98)10039-9 · Cited by 936
Lesions in the left arcuate fasciculus region and depressive symptoms in multiple sclerosis
Pujol, J., Bello, J., Deus, J., Martí-Vilalta, J. L., & Capdevila, A. (1997) · Neurology · doi:10.1212/wnl.49.4.1105 · Cited by 159
Prefrontal cortical hypometabolism during low-dose interferon alpha treatment
Juengling, F. D., Ebert, D., Gut, O., Engelbrecht, M. A., Rasenack, J., Nitzsche, E. U., Bauer, J., & Lieb, K. (2000) · Psychopharmacology · doi:10.1007/s002130000549 · Cited by 149
Cited by
Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., et al. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001805 · Cited by 794
Depression in multiple sclerosis: a review
Siegert, R. J. (2005) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.2004.054635 · Cited by 718
The Goldman Consensus statement on depression in multiple sclerosis
Goldman Consensus Group (2005) · Multiple Sclerosis Journal · doi:10.1191/1352458505ms1162oa · Cited by 329
Depression in multiple sclerosis
Patten, S. B., Marrie, R. A., & Carta, M. G. (2017) · International Review of Psychiatry · doi:10.1080/09540261.2017.1322555 · Cited by 262
Psychiatric Issues in Multiple Sclerosis
Chwastiak, L. A., & Ehde, D. M. (2007) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2007.07.003 · Cited by 166
Metadata
- Authors
- Zephir, H., De Seze, J., Stojkovic, T., Delisse, B., Ferriby, D., Cabaret, M., & Vermersch, P.
- Venue
- Multiple Sclerosis Journal
- Publisher
- SAGE Publications
- Published
- 2003-06
- Volume
- 9
- Issue
- 3
- Pages
- 284-288
- ISSN
- 1352-4585 (ISSN-L)
- 1477-0970
- OpenAlex
- W2162821925
- Cited by
- 73
- References
- 3
- FWCI
- 4.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multiple sclerosis and depression: influence of interferon b therapy. https://app.cochat.ai/papers/10.1191/1352458503ms915oa
- The paper
- Zephir, H., De Seze, J., Stojkovic, T., Delisse, B., Ferriby, D., Cabaret, M., & Vermersch, P. (2003). Multiple sclerosis and depression: influence of interferon b therapy. Multiple Sclerosis Journal. https://doi.org/10.1191/1352458503ms915oa
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.